| Business Name: |
Desikan Kamalakanna MD |
| Contact Person: |
Kamalakanna Desikan, |
| Address: |
1601 North Belt Line Road # C, Mesquite, Texas 75149 |
| Phone Number: |
(972) 279-3500 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
El-Ashram Nayer MD - Mesquite, TX 75149
Metroplex Pediatric Night Clinic - Mesquite, TX 75149
Jennifer Aldrich Md - Mesquite, TX 75149
Blakely James MD - Mesquite, TX 75149
Prescott Paul R MD - Mesquite, TX 75149
Joseph A Meachem Md - Mesquite, TX 75149
Cornell Thomas J MD - Mesquite, TX 75149
Anesthesia Care Pa - Mesquite, TX 75149
Kim Seong MD - Mesquite, TX 75149
Burney Mohammad MD - Mesquite, TX 75149
John Pataki Md Pa - Mesquite, TX 75149
Zopolsky Paul R MD - Mesquite, TX 75149
Rizwan Syed MD - Mesquite, TX 75149
Southern Endocrinology - Mesquite, TX 75149
Kirven Sharon D MD - Mesquite, TX 75149
Jose Ampil Peralta - Mesquite, TX 75149
Medical House Calls - Mesquite, TX 75149
Institute of Divine Meta - Mesquite, TX 75149
Parekh Sohail MD - Mesquite, TX 75149
Askins Randall MD - Mesquite, TX 75149
|
The company Desikan Kamalakanna MD provides B2C services in the form of Doctors from its single location in Texas.
1 to 4 employees work for Desikan Kamalakanna MD, and the business now earns $500.000 to $999.999 per annum.
Desikan Kamalakanna MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Desikan Kamalakanna MD, please call Kamalakanna Desikan, with the phone number (972) 279-3500 or visit its single location at 1601 North Belt Line Road # C in Mesquite, Texas 75149.
The location of the single location can also be found using the coordinates 32.78496,-96.5959.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.